Dr. Brian Kennedy Marks, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5 Washington Pl, Bedford, NH 03110 Phone: 603-695-2500 |
News Archive
What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.
In a Foreign Affairs essay, Secretary of State Hillary Rodham Clinton writes of the need to elevate diplomacy and development alongside defense a 'smart power' approach to solving global problems.
Kidney stones are a major cause of illness, according to background information in the article. The lifetime prevalence of kidney stones is approximately 10 percent in men and 5 percent in women, and more than $2 billion is spent on treatment each year.
The tyrosine kinase inhibitor vandetanib could significantly extend progression-free survival in patients with locally advanced or metastatic differentiated radioiodine-refractory thyroid cancer, show results of a small phase II randomized trial.
NIBIB-funded researchers have created nanoparticles for successful gene therapy of a mouse model of macular degeneration.
› Verified 8 days ago